| P/E (FY) | 35.6 | Sales (TTM) | SEK 6.56B |
| Earnings (TTM) | SEK 214.9M | ROE | 42.18% |
| Net Margin | 3.27% | ROIC | 36.67% |
| Debt / Equity | 0.13 | TD / EBITDA | 0.20 |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
Apotea AB operates an online pharmacy in Sweden, selling a broad range of health, personal care, and household products. Its assortment covers categories such as allergy, cold and fever relief, baby and child care, dietary supplements, body and hair care, beauty and makeup, and home and household goods. The company also leases out personnel to related companies and provides marketing contributions. Apotea was founded in 2011 and is headquartered in Stockholm, Sweden.
No price history for APOTEA.ST — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
No return history for APOTEA.ST, so risk analytics are unavailable.
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| SLDB | Solid Biosciences Inc. | $784.6M | — |
| SSII | SS Innovations International, Inc. | $786.5M | — |
| SIBN | SI-BONE, Inc. | $795.2M | — |
| AVR | Anteris Technologies Global Corp. | $795.3M | — |
| GNFT.PA | SA GENFIT | $775.2M | 454.7 |
| ANNX | Annexon, Inc. | $770.9M | — |
| CYRX | Cryoport, Inc. | $764.6M | 10.8 |
| OMER | OMEROS CORP | $816.4M | — |
| ESPR | Esperion Therapeutics, Inc. | $818.6M | — |
| CMMB | Chemomab Therapeutics Ltd. | $822.8M | 79.4 |
| KURA | Kura Oncology, Inc. | $826.5M | — |
| ARJO-B.ST |
| Arjo AB (publ) |
| $746.1M |
| 16.3 |
